Skip to main content

Table 1 Identification of MYC, BCL-2, and BCL-6 rearrangements in human DLBCL and BL cell lines: c-MYC, BCL-2, and BCL-6 rearrangements were analyzed with break-apart FISH in human DLBCL (n = 9) and Burkitt Lymphoma cell lines (n = 2)

From: Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors

DLBCL cell lines

cMYC

BCL-2

BCL-6

Status

U2932

Wild-type

Amplification

3–4 copies

WT-MYC

HBL-1

Wild-type

3 copies

Normal

WT-MYC

Raji (BL)

Rearrangement

3 copies

Normal

Single hit

Ramos (BL)

Rearrangement

1 copy

3 copies

Single hit

SUDHL2

Rearrangement/amplification

Rearrangement

3 copies

Double hit

OCILY1

Rearrangement/amplification

Rearrangement

3 copies

Double hit

OCILY10

Rearrangement/amplification

Rearrangement

3 copies

Double hit

DOHH2

Rearrangement/amplification

Rearrangement

Normal

Double hit

VAL

Rearrangement

Rearrangement

Rearrangement

Triple hit

OCILY3

3–4 copies

Rearrangement

Rearrangement

BCL2/BCL6 translocation

OCILY19

3–4 copies

Rearrangement

Rearrangement

BCL2/BCL6 translocation